I hope there is no paring back of subscriptions. Just take as much money as they can as it would be needed once US is open for business. This SPP is really a no brainer for shareholders. No matter the price comes in at, once the FDA approval is given, the share price will more than double easily. And then naturally there will be plenty of aged care beds signing up from the US after that.
Exciting times ahead!
PCK Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
